3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
12
Phase 1
7
Phase EARLY_PHASE1
2
Phase NA
1
Phase 4
1
Phase 3
1
Phase 2/3
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma
6
Leukemia
6
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Non-Hodgkin
4
Recurrence
3
Sezary Syndrome
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Follicular
2
Leukemia, T-Cell
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Congenital Abnormalities
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Teratoma
1
Small Cell Lung Carcinoma
1
Seminoma
1
Sarcoma, Ewing
1
Retinoblastoma
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Neuroblastoma
1
Neoplasms
1
Myeloproliferative Disorders
1
Interventions
Carboplatin
2
trofosfamide
1
Vincristine
1
Thiotepa
1
Temozolomide
1
Radiotherapy
1
Maintenance Chemotherapy
1
Lomustine
1
Induction Chemotherapy
1
Etoposide
1
Diploidy
1
Cyclophosphamide
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Medulloblastoma
×
Etoposide
×
Clear all
NCT00749723
2018-07-20
HIT-REZ-2005
University Hospital, Bonn
Phase 2/3
Completed
174 enrolled